Tamayo Louis Edward
Insider CIK 2083206 · LXEO Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LXEO Lexeo Therapeutics, Inc. | A Award deriv | 2026-09-24 | 2026-09-28 | 54,750 | — | $0 | 54,750 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award deriv | 2026-09-24 | 2026-09-28 | 54,750 | — | $0 | 54,750 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-19 | 4,117 | $4.91 | $20.2K | 92,907 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-19 | 4,117 | $4.91 | $20.2K | 92,907 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2026-07-01 | 2026-07-01 | 4,641 | $4.49 | $20.8K | 97,024 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award | 2026-06-29 | 2026-07-01 | 12,000 | — | $0 | 101,665 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award deriv | 2026-02-04 | 2026-02-06 | 226,665 | — | $0 | 226,665 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award | 2026-02-04 | 2026-02-06 | 44,665 | — | $0 | 89,665 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award deriv | 2025-08-29 | 2025-09-03 | 280,000 | — | $0 | 280,000 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award | 2025-08-29 | 2025-09-03 | 45,000 | — | $0 | 45,000 | SEC↗ |